DOP&PW
Pharma industry seeks relief from price cap rule for cheap drugs
India’s FoPE seeks a 10-year exemption for patented and low-cost drugs from price controls. Requests include DPCO and 12% GST adjustments due to 15-130% ingredient cost rises. Presenting to the DoP secretary, FoPE cites working capital issues prompting overseas research. Supported by IPA, Harish Jain stressed necessary revisions.
Nutraceuticals may get cheaper as panel looks to regulate prices
The Indian government is contemplating bringing nutraceuticals under price control to enhance affordability for consumers. Currently regulated by the Food Safety and Standards Authority of India (FSSAI) without price controls, these products, often marketed as over-the-counter health supplements, face scrutiny for high pricing. Officials argue that some companies charge exorbitant prices by repackaging pharmaceutical ingredients into nutraceuticals. A committee involving various health and regulatory bodies aims to introduce pricing regulations to curb this trend and ensure fair pricing.
Drug regulator to crack down on pharma companies not using barcodes
The drug regulator is also considering setting up a joint task force for fighting the menace of spurious and adulterated drugs in the country, people in the know told ET.
Pharma bosses told to submit affidavits on ethical practices
Pharmaceutical companies asked to submit undertaking to government for compliance with UCPMP 2024 by June 30, as per DoP circular dated May 28.
Medical devices companies to soon have 'unique' pricing model
At present there is no separate pricing framework followed for medical devices. The government has been using the same framework which was created for drugs in case they want to regulate the price of any medical device. Earlier, it had regulated the prices of stents and knee implants under the Drug Price Control Order.
Panel to review prices of drugs, medical devices
The government has constituted a panel to reform the pricing framework for drugs and medical devices. The committee will evaluate the availability and pricing of essential medicines, balance price and availability, and consider institutional reforms within the NPPA. It will also design a price moderation framework for medical devices and minimize imports.
- Go To Page 1
Govt notifies new marketing code for pharma industry
The government has implemented a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) to control unethical practices in the pharma industry. The code prohibits companies from offering gifts, workshops, or free samples to healthcare professionals and aims for an ethical transformation.
Govt announces revamped technology upgradation assistance scheme for pharma units
The Department of Pharmaceuticals (DoP) has announced the Revamped Pharmaceuticals Technology Upgradation Assistance (RPTUAS) scheme to enhance the technological capabilities of the pharmaceutical industry, aligning it with global standards. The scheme covers pharmaceutical units with a turnover of less than Rs 500 crore for the last three years, offering incentives of up to Rs 1 crore.
Investments worth Rs 25,813 crore made under pharma PLI as of Sept 2023: Govt
The government has announced that investments totalling Rs 25,813 crore have been infused into the pharmaceutical sector, leading to the addition of 56,171 new jobs under the production-linked incentive scheme till September this year. In its year-end review, the Department of Pharmaceuticals (DoP) also highlighted the successful accomplishment of the 'Pradhan Mantri Bhartiya Janaushadhi Pariyojana,' meeting its goal of establishing 10,000 retail outlets in 2023.
India's pharma industry has far to go to account for 20% of manufacturing sector
India's pharma industry has to grow by 3-4 times to account for 20% of manufacturing sector, said Arunish Chawla, secretary department of pharmaceuticals (DOP) said today at the CII Lifesciences summit. Known as the pharmacy of the world, India’s pharma sector exported $50 billion last year.
Pharma industry needs to focus on innovative products to achieve global leadership: Mansukh Mandaviya
While formally unveiling the National Policy on Research & Development and Innovation in the Pharma-Med Tech Sector in New Delhi, Mandaviya said the domestic pharmaceutical companies invest less on research and development when compared to multinational companies.
Packages of top drug brands to have QR codes from today
The National Pharmaceuticals Pricing Authority (NPPA) had last year identified brands including Dolo, Saridon Fabiflu, Ecosprin, Limcee, Sumo, Calpol, Corex syrup, Unwanted 72 and Thyronorm. They were shortlisted on the basis of their moving annual turnover value as per data from market research firm Pharmatrac.
Medical device packs will have to display key info
All medical devices will have to bear details like retail price, country of origin, size and dimensions and consumer care details on the package so that consumers can make an informed decision, the department of consumer affairs has said.
Prices of drugs going off patent to be slashed to 50%
In case of Fixed dose combinations (FDC) where one component is going off patent the ceiling price will be revised by reducing the present ceiling price by 50%, it further said. According to the notification, "the retail price of the new drug shall be arrived at by reducing fifty percent," it said. The Centre and the pharma industry had been working on a pricing mechanism for drugs that are going off patent for a year now.
Govt to discuss TMR with pharma bodies on May 16
In this regard, the Department of Pharmaceuticals (DoP) and the National Pharmaceutical Pricing Authority (NPPA) have invited members of pharma associations and medical device manufacturers for the meeting and sought their suggestions by Friday.
Government focussing on production of high value pharmaceuticals: Mansukh Mandaviya
Mandaviya said the Department of Pharmaceuticals (DoP) has released the first tranche of incentives under the Product Linked Incentive (PLI) scheme of pharmaceuticals amounting to Rs 166 crore to four selected applicants.
Fan of cheese! Swiss cheese Le Gruyère adjudged the best at the World Cheese Awards
In the contest, judges worked in teams of three to identify any cheeses that were worthy of gold, silver, or bronze award. They judged the rind and the body of the cheese, its colour, texture, consistency and above all its taste. Each of the teams then nominated one exceptional cheese as the ‘super gold’. The narrowed list of ‘super gold’ cheese is then further cut down to a finalist list with 16 entries.
Marketing practices framework: DoP panel to meet drug lobby groups
"In the meeting as part of stakeholder consultations, the committee has desired to have the view of Organisation of Pharmaceutical Producers of India (OPPI), Indian Pharmaceutical Alliance (IPA), Indian Drug Manufactuers' Association (IDMA)," said a notice issued by the DoP on the meeting, which be held on November 4.
Medical device makers may be exempted from packaging rules
The Department of Pharmaceuticals, which has reconstituted the National Medical Devices Promotion Council, will hold its first meeting on Wednesday. On the council's agenda is discussion around "exemption of licensed manufacturers of medical devices from the Legal Metrology (Packaged Commodities) Rules, 2011".
India Post warns customers of fraud websites claiming to offer subsidies
The Department of Post (DoP) has warned its consumers via SMS not to fall victim to bogus claims providing government incentives through India Post.
49 applications approved under PLI scheme for bulk drugs: Govt
Earlier this month, DoP had extended the date of receipt of applications till March-end for the vacant slots under the PLI scheme for the promotion of domestic manufacturing of bulk drugs.
Defence ministry increases maximum limits of two family pensions payable to child
Department of Pension and Pensioners' Welfare has revised maximum ceiling limits of two family pension payable to a child or children in respect of both the parents to Rs 1.25 lakh per month and Rs 75,000 per month.
Remdesivir production will be up from 38.80 lakh units/month to 74 lakh units/month by May: MHA
Union Home Secretary Ajay Bhalla, in a letter to chief secretaries of all states and Union territories (UTs), also conveyed that there will be interim allocation and supply of the life-saving injection to the states/UTs from April 21 to April 30.
India Post will not process articles in absence of correct disclosure by customers: DoP
The DoP said as per rules, it is mandatory that all postal articles including ordinary articles containing goods meant for delivery to foreign destinations are affixed with correct and complete relevant custom declaration forms.
Centre does a U-turn, says no plans to make pharmaceutical marketing code mandatory
On September 18, when chemicals minister DV Sadananda Gowda was asked if the government had decided to make the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) mandatory, he said no. This is a u-turn from the government reply in the Lok Sabha on May 15, 2016 when it said: “...code was reviewed and it was now decided to make it statutory. Once the code is made statutory it is expected that the unethical practices could be controlled more effectively.”
Department of Pharma proposes Rs 10,000-crore incentive scheme for promoting domestic API units
The proposal is likely to be put before the union cabinet tomorrow, people in the know told ET. Under the proposal, the government will provide financial incentive to those pharma companies ready to invest Rs 500 crore in an existing or new plant.
Incentives scheme on cards to give impetus to API manufacturing
The Department of Pharmaceuticals (DoP) has proposed creation of a corpus fund of Rs 3,000 crore for companies that are interested in setting up API or fermentation units in India, people in the know told ET.
Pharma companies must adhere to marketing norms during conferences: Govt
Asking the lobbies to ensure that no unethical promotion of pharma products is done during conferences, it said companies must adhere to the Universal Code of Pharmaceutical Marketing Practices (UCPMP) during the upcoming annual conferences of Indian Psychiatric Society, which are to be held in Kolkata and Visakhapatnam.
Load More
